Abstract
To evaluate the clinicopathological significance of matrix metalloproteinase‐7 (MMP‐7) expression in gastric carcinoma, we investigated immunohistochemically MMP‐7 expression in 214 gastric carcinomas, and examined its relations with the clinicopathologic parameters including patient prognosis. MMP‐7 expressed predominantly in cancer cells, and MMP‐7‐positive tumor cells were preferentially found in deeply invading nests, especially at the invasive front. The mean MMP‐7 labeling index (LI) at the invasive front was significantly higher in tumors invading or penetrating the muscularis propria and in stages II‐IV than within the submucosal layer and in stage I, respectively (P<0.001). Statistical analysis revealed that MMP‐7 LI at the invasive front was related to lymph node metastasis, vascular invasion, and lymphatic permeation, when all 214 cases were examined as one group (P<0.05 for all), and the cases with high MMP‐7 expression at the invasive front showed significantly more unfavorable prognosis as compared with that of low MMP‐7 expression tumors (P<0.01). Multivariate analysis revealed that TNM stage and MMP‐7 expression status at the invasive front were independent prognostic factors (P=0.0017, relative risk (RR)=3.12; P=0.0019, RR=2.67, respectively). Our findings indicated that expression of MMP‐7 at the invasive front is closely associated with local invasiveness, and might be a reliable prognostic marker for patients with gastric carcinoma.
Keywords: Gastric carcinoma, Matrix metalloproteinase‐7 (MMP‐7), Immunohistochemistry, Prognosis
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
REFERENCES
- 1.Crawford , H. C. and Matrisian , L. M.Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression . Invasion Metastasis , 14 , 234 – 245 ( 1995. ). [PubMed] [Google Scholar]
- 2.Stetler‐Stevenson , W. G. , Aznavoorian , S. and Liotta , L. A.Tumor cell interactions with the extracellular matrix during invasion and metastasis . Annu. Rev. Cell Biol. , 9 , 541 – 573 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 3.Matrisian , L. M.The matrix‐degrading metalloproteinases . Bioessays , 14 , 455 – 463 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 4.Miyazaki , K. , Hattori , Y. , Umenishi , F. , Yasumitsu , H. and Umeda , M.Purification and characterization of extracellular matrix‐degrading metalloproteinase, matrin (pump‐1), secreted from human rectal carcinoma cell line . Cancer Res. , 50 , 7758 – 7764 ( 1990. ). [PubMed] [Google Scholar]
- 5.Wilson , C. L. and Matrisian , L. M.Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions . Int. J. Biochem. Cell Biol. , 28 , 123 – 136 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 6.Sires , U. L , Murphy , G. , Baragi , V. M. , Fliszar , C. J. , Welgus , H. G. and Senior , R. M.Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1‐antitrypsin . Biochem. Biophys. Res. Commun. , 204 , 613 – 620 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 7.Honda , M. , Mori , M. , Ueo , H. , Sugimachi , K. and Akiyoshi , T.Matrix metalloproteinase‐7 expression in gastric carcinoma . Gut , 39 , 444 – 448 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Yamamoto , H. , Adachi , Y. , Itoh , F. , Iku , S. , Matsuno , K. , Kusano , M. , Arimura , Y. , Endo , T. , Hinoda , Y. , Hosokawa , M. and Imai , K.Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma . Cancer Res. , 59 , 3313 – 3316 ( 1999. ). [PubMed] [Google Scholar]
- 9.Yamashita , K. , Mori , M. , Shiraishi , T. , Shibuta , K. and Sugimachi , K.Clinical significance of matrix metalloproteinase‐7 expression in esophageal carcinoma . Clin. Cancer Res. , 6 , 1169 – 1174 ( 2000. ). [PubMed] [Google Scholar]
- 10.Adachi , Y. , Yamamoto , H. , Itoh , F. , Arimura , Y. , Nishi , M. , Endo , T. and Imai , K.Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers . Int. J. Cancer , 95 , 290 – 294 ( 2001. ). [DOI] [PubMed] [Google Scholar]
- 11.Adachi , Y. , Itoh , F. , Yamamoto , H. , Matsuno , K. , Arimura , Y. , Kusano , M. , Endoh , T. , Hinoda , Y. , Oohara , M. , Hosokawa , M. and Imai , K.Matrix metalloproteinase matrilysin (MMP‐7) participates in the progression of human gastric and esophageal cancers . Int. J. Oncol. , 13 , 1031 – 1035 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 12.Yamashita , K. , Azumano , L , Mai , M. and Okada , Y.Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis . Int. J. Cancer , 79 , 187 – 194 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 13.Senota , A. , Itoh , F. , Yamamoto , H. , Adachi , Y. , Hinoda , Y. and Imai , K.Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer . Clin. Exp. Metastasis , 16 , 313 – 321 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 14.Nishi , M. , Omori , Y. and Miwa , K. “ Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma ,” First English Ed. ( 1995. ). Kanehara & Co., Ltd. , Tokyo . [Google Scholar]
- 15.Sobin , L. H. and Wittekind , Ch. “ International Union against Cancer. TNM Classification of Malignant Tumors ,” 5th Ed. , pp. 59 – 62 ( 1997. ). John Wiley & Sons, Inc. , New York . [Google Scholar]
- 16.Kawauchi , S. , Goto , Y. , Liu , X. P. , Furuya , T. , Oga , A. , Oda , Y. , Tsuneyoshi , M. , Ihara , K. and Sasaki , K.Low expression of p27 (Kipl), a cyclin‐dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma . Cancer , 91 , 1005 – 1012 ( 2001. ). [PubMed] [Google Scholar]
- 17.Liu , X. P. , Kawauchi , S. , Oga , A. , Suehiro , Y. , Tsushimi , K. , Tsushimi , M. and Sasaki , K.Combined examination of p27Kip1, p21Wafl/cip1 and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma . Histopathology , 39 , 1 – 8 ( 2001. ). [DOI] [PubMed] [Google Scholar]
- 18.Mayer , B. , Johnson , J. P. , Leitl , F. , Jauch , K. W. , Heiss , M. M. , Schildberg , F. W. , Birchmeier , W. and Funke , I.E‐Cadherin expression in primary and metastatic gastric cancer: down‐regulation correlates with cellular dedifferentiation and glandular disintegration . Cancer Res. , 53 , 1690 – 1695 ( 1993. ). [PubMed] [Google Scholar]
- 19.Yamamoto , H. , Itoh , F. , Hinoda , Y. and Imai , K.Inverse association of cell adhesion regulator messenger RNA expression with metastasis in human colorectal cancer . Cancer Res. , 56 , 3605 – 3609 ( 1996. ). [PubMed] [Google Scholar]
- 20.Miyazaki , K. , Kikkawa , Y. , Nakamura , A. , Yasumitsu , H. and Umeda , M.A large cell‐adhesive scatter factor secreted by human gastric carcinoma cells . Proc. Natl. Acad. Sci. USA , 90 , 11767 – 11771 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hakomori , S.Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism . Cancer Res. , 56 , 5309 – 5318 ( 1996. ). [PubMed] [Google Scholar]
- 22.Nemunaitis , J. , Poole , C. , Primrose , J. , Rosemurgy , A. , Malfetano , J. , Brown , P. , Berrington , A. , Cornish , A. , Lynch , K. , Rasmussen , H. , Kerr , D. , Cox , D. and Millar , A.Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer‐term studies . Clin. Cancer Res. , 4 , 1101 – 1109 ( 1998. ). [PubMed] [Google Scholar]